Business
Biotalys and 21st.BIO Enter into Strategic Partnership to Advance Biocontrol Production
Biotalys Provides Update on Its Plans to Fund Next Phase of DevelopmentGhent, BELGIUM, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Press release – inside information* Biotalys (Euronext: BTLS) and 21st.BIO, a leading Danish precision fermentation technology company, have entered into a strategic partnership to accelerate the production of Biotalys’ protein-based biocontrol solutions. This collaboration will leverage 21st.BIO’s proprietary fermentation platform to support the production of Biotalys’ AGROBO
About this update from Biotalys Nv
[{"type":"image","alt":"Biotalys NV","displaySize":"","headline":null,"caption":"Biotalys NV","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":130,"url":"https://media.zenfs.com/en/globenewswire.com/c55e0561d828df8274a2912a66aac666"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/TlySAVfJ1RacwS3IDFpoeg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE4MjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/c55e0561d828df8274a2912a66aac666","width":300,"height":130}},"lazy":false},{"type":"text","content":"Biotalys Provides Update on Its Plans to Fund Next Phase of Development","length":71,"tagName":"p"},{"type":"text","content":"Ghent, BELGIUM, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Press release – inside information*","length":85,"tagName":"p"},{"type":"text","content":"Biotalys (Euronext: BTLS) and 21st.BIO, a leading Danish precision fermentation technology company, have entered into a strategic partnership to accelerate the production of Biotalys’ protein-based biocontrol solutions. This collaboration will leverage 21st.BIO’s proprietary fermentation platform to support the production of Biotalys’ AGROBODY agricultural biocontrol products at commercially competitive costs.","length":413,"tagName":"p"},{"type":"text","content":"21st.BIO offers an industry-leading precision fermentation platform, powered by production strains refined over more than four decades and proven in broad commercial use. Part of 21st.BIO’s advanced precision fermentation technology is licensed from Novonesis, and the new collaboration will integrate 21st.BIO’s capabilities with prior work conducted by Biotalys and Novonesis. This collaboration is expected to expand process development options and support efficient, large-scale manufacturing of Biotalys’ precision biocontrol products.","length":540,"tagName":"p"},{"type":"text","content":"“This partnership marks an important strategic step in strengthening the technical backbone of our AGROBODY platform,” said Kevin Helash, CEO of Biotalys. “By combining 21st.BIO’s proven fermentation expertise with our own innovation in protein-based biocontrols, we are reinforcing the foundation needed to support a growing and differentiated product portfolio.”","length":364,"tagName":"p"},{"type":"text","content":"“Our collaboration with Novonesis and its relationship to 21st.BIO were critical in unlocking this next s...